Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,827 articles
FIRST STUDENT TEAMSTERS AUTHORIZE STRIKE
Over 17,000 Bus Workers Nationwide Ready to Strike for a Fair Agreement WASHINGTON, March 25, 2026 /PRNewswire/ -- Teamsters school bus workers at...
📰
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
GAITHERSBURG, Md., March 25, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced it has secured a contract award valued...
Amazon To Rally Around 49%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and...
Amazon To Rally Around 49%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and...
Amazon To Rally Around 49%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and...
📰
Bragar Eagel & Squire, P.C. Reminds Ultragenyx (NASDAQ: RARE) Investors of the Upcoming April 6th Lead Plaintiff Deadline and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ultragenyx (RARE) To Contact Him...
📰
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Added top-rated children's hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base
Completed enrollment in...
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
LOS ANGELES, March 25, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage...
📰
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
ISELIN, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the...
Precigen Reports Full Year 2025 Financial Results and Business Updates
Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS™ (zopapogene imadenovec-drba), the first-and-only...
📰
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
ISELIN, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the...
📰
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Evaluating Potential to Preserve Muscle Mass Associated with Weight Reduction
📰
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Added top-rated children’s hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base
📰
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Evaluating Potential to Preserve Muscle Mass Associated with Weight Reduction
Announces Preclinical Study Initiation, Patent Filing and Publication...
📰
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Initiation of Phase 1 proof-of-mechanism study of EQ504 planned for mid-2026, with data expected approximately six months thereafter
📰
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
<ul xmlns="http://www.w3.org/1999/xhtml" type="disc">
<li xmlns="http://www.w3.org/1999/xhtml"><b...
📰
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine
The Company continues to advance the program, with the...
📰
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
<p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml"...
📰
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine
📰
MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Mereo (MREO) To Contact Him Directly To...
📰
Where Will Vertex Pharmaceuticals Be in 1 Year?
The biotech's recent dip might be a buying opportunity.
📰
LEEF Brands Reports Fourth Quarter And Full Year 2025 Results; Salisbury Canyon Ranch Drives Margin Expansion And Mindset Capital Investment Fuels Next Phase Of Growth
VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE:LEEF) (OTCQB:LEEEF) ("LEEF" or the "Company"), a rapidly...
📰
LEEF Brands Reports Fourth Quarter And Full Year 2025 Results; Salisbury Canyon Ranch Drives Margin Expansion And Mindset Capital Investment Fuels Next Phase Of Growth
LEEF reports Q4 2025 results with 39% revenue growth, doubled gross margins to 45.5%, positive EBITDA and free cash flow, driven by vertical...
📰
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
WINSTON-SALEM, N.C., March 25, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage...
📰
Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
MINNEAPOLIS, March 25, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of...
📰
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024
📰
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024
📰
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
📰
Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<ul...
📰
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing...
📰
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
Dose escalation for NKX019 advanced to 4 billion cells per dose on days 0, 3 and 7 for a total of 12 billion cells per cycle
Initial clinical data...
This Mondelez Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
Crude Oil Moves Lower; Cintas Raises FY2026 Forecast
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.
The Dow traded up 0.60% to...
Crude Oil Moves Lower; Cintas Raises FY2026 Forecast
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.
The Dow traded up 0.60% to...
Crude Oil Moves Lower; Cintas Raises FY2026 Forecast
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.
The Dow traded up 0.60% to...
📰
Moderna Stock is Soaring. Is It Too Late to Buy?
Moderna's full pipeline may fuel long-term growth.
📰
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show.
Strategic Collective Launches "Speak Your Way to Sales" to Dismantle the Referral-Only Glass Ceiling for Speakers
Women hold only 33% of keynote slots due to "referral-only" loops. Speak Your Way to Sales (Eaton Press) is a tactical roadmap from 10 leaders to...